MAPT and Alzheimer disease: Using one mouse strain that expresses β-amyloid plaques and one mouse strain that expresses Tau protein-associated neurofibrillary tangles allowed us to distinguish between the impact of these two AD-related neuropathologies on sensory and cognitive performance.